Bosentan added to sildenafil therapy in patients with pulmonary ...

The safety and efficacy of adding bosentan to sildenafil in pulmonary arterial hypertension (PAH) patients was investigated.In this prospective ...

Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension · CITATION MANAGER FORMATS · Share. Copy link.

Combination therapy with bosentan and sildenafil in idiopathic ...

These preliminary data suggest that combining bosentan and sildenafil may be safe and effective in patients with idiopathic pulmonary arterial hypertension.

Bosentan combined with sildenafil in the treatment of COPD patients ...

The combination of bosentan and sildenafil has been shown to improve and control pulmonary hypertension [15]. However, there are few studies on whether the two ...

Bosentan added to sildenafil therapy in patients with pulmonary ...

Vallerie McLaughlin, Richard N. Channick, Hossein-Ardeschir Ghofrani, Jean-Christophe Lemarié, Robert Naeije, Milton Packer, Rogério Souza, ...

Addition of sildenafil to bosentan monotherapy in pulmonary arterial ...

The present authors reviewed their experience with the addition of sildenafil to bosentan therapy in patients with both IPAH and PAH-SSD who had deteriorated ...

Sildenafil dosed concomitantly with bosentan for adult pulmonary ...

Sildenafil, in addition to stable (≥3 months) bosentan therapy, had no benefit over placebo for 12-week change from baseline in 6MWD.

THE ADDITION OF SILDENAFIL TO BOSENTAN THERAPY IN THE ...

CLINICAL IMPLICATIONS: Addition of sildenafil to bosentan therapy may be of benefit in patients with pulmonary arterial hypertension. Long-term ...

Combination therapy with bosentan and sildenafil in Eisenmenger ...

In Eisenmenger syndrome, treatment with bosentan significantly improved walking distance, pulmonary blood flow, and PVR. Adding sildenafil to ...

Bosentan added to sildenafil therapy in patients with pulmonary ...

In COMPASS-2, adding bosentan to stable sildenafil therapy was not superior to sildanafil monotherapy in delaying the time to the first morbidity/mortality ...

Bosentan–sildenafil association in patients with congenital heart ...

Addition of sildenafil in adult patients with CHD-related PAH and Eisenmenger syndrome after oral bosentan therapy failure is safe and well tolerated at 6- ...

Bosentan added to sildenafil therapy in patients with pulmonary ...

Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension. ... The safety and efficacy of adding bosentan to sildenafil in pulmonary ...

Sildenafil Plus Bosentan for PAH: What's the Verdict? - Medscape

Bosentan Added to Sildenafil Therapy in Patients With Pulmonary Hypertension. McLaughlin V, Channick RN, Ghofrani HA, et al. Eur Respir J ...

[PDF] Combination therapy with bosentan and sildenafil in idiopathic ...

Preliminary data suggest that combining bosentan and sildenafil may be safe and effective in patients with idiopathic pulmonary arterial hypertension.

Bosentan added to sildenafil therapy in patients with pulmonary ...

Request PDF | Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension | The safety and efficacy of adding bosentan to ...

Pharmacokinetic and Pharmacodynamic Comparison of Sildenafil ...

✓ Our results provide evidence to support transition from bosentan to ambrisentan in patients with pulmonary arterial hypertension also treated ...

Bosentan–sildenafil association in patients with congenital heart ...

Addition of sildenafil in adult patients with CHD-related PAH and Eisenmenger syndrome after oral bosentan therapy failure is safe and well tolerated at 6-month ...

BOSENTAN IMPROVES HEMODYNAMICS IN PATIENTS ...

CONCLUSION: In mildly symptomatic, sildenafil-treated PAH patients, add-on bosentan therapy improved hemodynamics and suggests a delay in clinical worsening, ...

Safety and efficacy of transitioning from the combination of bosentan ...

The combination of bosentan and sildenafil is commonly used to treat patients with pulmonary arterial hypertension (PAH); however, ...

Comparison of the Effects of Bosentan and Sildenafil in the

Bosentan as an endothelin type A and B receptor antagonist and sildenafil as a phosphodiesterase inhibitor type 5 are effective in reducing pulmonary vascular ...